Hawaii Biotech Receives NIAID Grant for Chikungunya Virus Vaccine Development
Hawaii Biotech Inc. has been selected to develop a vaccine against chikungunya virus under a Small Business Innovation Research Phase I grant from the National Institutes of Health‘s National Institute of Allergy and Infectious Diseases. The biotechnology company said Tuesday it will collaborate with the Sabin Vaccine Institute and Baylor College of Medicine on the project. David Clements, director of […] More